About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Janssen Biotech
›
Top Articles
Janssen Biotech
8
(top 1%)
papers
238
(top 1%)
citations
4
(top 1%)
h
-index
7
(top 1%)
g
-index
10
all documents
458
doc citations
204
citing journals
2
times ranked
Top Articles
#
Title
Journal
Year
Citations
1
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia
Blood
2018
170
2
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Blood
2023
52
3
In VitroResponse to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B Vaccine
Hepatology
1984
22
4
Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible for Transplant (ALCYONE)
Blood
2017
12
5
Thin-layer chromatography of endotoxins, their derivatives and contaminants
Journal of Chromatography A
1988
5
6
Ustekinumab neutralizes human IL‐12 and IL‐23 mediated Th1 and Th17 cell function and provides clinical benefit to patients with plaque psoriasis
FASEB Journal
2008
1
7
15440 Cost-per-responder analysis of guselkumab versus secukinumab in obese patients using efficacy results from the ECLIPSE head-to-head clinical trial
Journal of the American Academy of Dermatology
2020
0
8
Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy.
Journal of Clinical Oncology
2013
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.